This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
JOGO is the first-ever digitaltherapeutics product to use the science of EMG biofeedback to treat neuromuscular diseases. Silverman and the late Joseph Brudny, M.D., the former Director of the Sensory Feedback Unit at ICD Research and Rehabilitation Center in Manhattan, were the original pioneers of EMG biofeedback in the 1970s.
The company will focus on building its digital proprietary platform and easy-to-use digital application. Thrivio Health, North Bergen – $400,000 Thrivio Health offers an AI-driven healthcare platform and digitaltherapeutics for primary care, urgent care, mental health, and pediatric care.
Digitaltherapeutics will rewrite the future of healthcare. Digitaltherapeutics is perhaps the most innovative development in healthcare today and has the potential to dramatically change how care is delivered.
Psychedelic medicine is spawning new companies in every part of the healthcare and life sciences ecosystem, including areas within drug discovery, manufacturing, clinics and retreats, telemedicine and other digitaltherapeutics, as well as consumer packaged goods.
With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digitaltherapeutics specialized in mental illness. million Series B, which was three times oversubscribed within two months. In addition, the proceeds will be used to increase its headcount.
Register Biofourmis , a Sigapore-founded digitaltherapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?
Our overall focus is and has always been on central nervous system (CNS), and we are agnostic as to the modality, be it psychedelic drug development, other pharmacological approaches, medtech devices, or digitaltherapeutics.
startup that offers personalized digitaltherapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K. based VC firm Optum Ventures, as it gears up to hop over the pond.
A year ago, MedRhythms’ digitaltherapeutic product received Breakthrough Device designation from the U.S. Neuroplasticity is how we can learn new things or why people with brain deficits can improve.”. MedRhythms’ product cycle. Image Credits: MedRhythms.
MedRhythms, a Portland, Maine-based digitaltherapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?
Moving Analytics (Movn), a virtual at-home intervention program for high-risk cardiac patients, claims to be “the most clinically validated” cardiac rehabilitation program on the market.
Neuroglee Therapeutics , a startup developing digitaltherapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digitaltherapeutics for neurodegenerative diseases. Neuroglee gets $2.3 Venture investing in elder tech.
Digitaltherapeutics company HAII (CEO Jinwoo Kim) announced on the 20th of last month that its cognitive function evaluation and personalized improvement service, ‘Alzguard-T,’ was officially selected as an innovative […]
The post [Medisafe in Mobi Health News] Improving digitaltherapeutics in non-visit based care appeared first on OurCrowd Blog. There needs to be collaboration between the healthcare professional and the patient as opposed to the “carwash model” of healthcare, says Medisafe CMO Dr. Danny Sands. Watch more here.
We’re excited to share that metaMe Health , a prescription digitaltherapeutics (PDT) company, today announced raising $2.2M in funding. HPA led the round , which will help metaMe continue its preparations for Regulora’s market launch and the build out of metaMe’s commercial infrastructure.
BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digitaltherapeutics for Alzheimer’s and related dementias.
In October, Limbix, a company creating digitaltherapeutics for adolescents, released data from a trial on its new product: SparkRx. Ultimately, SparkRx intends to submit for FDA approval of its digital therapy program. The company, says Alouf, is aiming to have SparkRx become a prescription-based digitaltherapeutic. .
We’re excited to share that metaMe Health , a prescription digitaltherapeutics (PDT) company, today announced raising $2.2M in funding. HPA led the round , which will help metaMe continue its preparations for Regulora’s market launch and the build out of metaMe’s commercial infrastructure.
The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in DigitalTherapeutics for Chronic Care D appeared first on OurCrowd Blog. Read more here.
The post [Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digitaltherapeutic platform appeared first on OurCrowd Blog.
BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digitaltherapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.
Global digitaltherapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. The post [DarioHealth in Yahoo Finance] Walmart Starts Distributing the DarioHealth Digital Diabetes Management System appeared first on OurCrowd.
Sweetch, a digitaltherapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, recently announced the completion of a $20 million Series A round of funding. Read more here.
Sweetch, a digitaltherapeutics innovator and creator of the precision engagement platform for chronic conditions, today announced it has been named a winner in the 2022 BIG Innovation Awards healthcare category, presented by the Business Intelligence Group. Read more on PR Newswire here.
Nasdaq: DRIO), a pioneer in the global digitaltherapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. NEW YORK, Jan. 21, 2021 /PRNewswire/ — DarioHealth Corp. Read more here.
(NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digitaltherapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in (..)
CB Insights on Thursday named Sweetch, a digitaltherapeutics innovator and creator of a hyper-personalized engagement platform for chronic conditions, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. Read more here.
Nasdaq: DRIO), a pioneer in the global digitaltherapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here. DarioHealth Corp.
Medisafe, a leading evidenced-based digitaltherapeutics company collaborating with healthcare organizations to provide medication management solutions for patients, today announced their new capabilities to integrate pharmacy services providing the last mile of services and completing a holistic patient journey management solution for medication management. (..)
Nasdaq: DRIO), a global digitaltherapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. NEW YORK, May 6, 2020 /PRNewswire/ — DarioHealth Corp. Food and Drug.
TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digitaltherapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. Gabbay M.D., has joined the company as an advisor.
16, 2022 Sweetch, a digitaltherapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS has joined the company as an advisor. TEL AVIV, Israel, Nov.
Nasdaq: DRIO), a global digitaltherapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.
Medisafe, a leading digitaltherapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.
This tech-driven movement (broadly) runs the gamut from telehealth platforms and chatbots (which aim to optimize access to human clinicians and thereby tackle resource scarcity); to a growing range of quantified health and fitness gizmos (which encourage consumers to self-monitor various biomarkers and typically nudge them to participate in beneficial (..)
Neuroglee , a Singapore-based health tech startup, wants to help with a digitaltherapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digitaltherapeutics company Biofourmis. million in pre-seed funding. The round was led by Eisai Co.,
Digitaltherapeutics. back to fundamentals. will the patients use it? how do you get to the doctors to get a prescription (channel access with pharma reps is not working). and somebody willing to pay for it (payers.
Swing Therapeutics, a digitaltherapeutics startup, has received an FDA breakthrough device designation for their 12-week smartphone-assisted fibromyalgia management program. Swing Therapeutics was founded in 2019 and has raised a total of $9 million in seed funding led by JAZZ Venture Partners. Neuroglee gets $2.3
Nasdaq: DRIO), a pioneer in the global digitaltherapeutics market, today announced that it will host a key opinion leader (KOL) call on digitaltherapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. DarioHealth Corp. Eastern Time. Read more here.
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digitaltherapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019.
Today’s entrepreneur is Omri Shor is co-founder and CEO of Medisafe, a digitaltherapeutic companion company helping patients manage their treatment journey and medication therapies, which just raised a $30 million round of funding. Read more here.
Medisafe, a leading digitaltherapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content